Technology Networks

EU-Funded TRANSCAN-3 Project Marks Milestones in Personalized Immunotherapy for Esophageal ...

TRANSCAN-3 advances personalized T-cell therapies for esophageal cancer with progress in neoantigen discovery and T-cell ...
TMCnet

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES ...

CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies ...